{
    "id": 28520,
    "fullName": "NT5E over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "NT5E (CD73) over exp indicates an over expression of the NT5E (CD73) protein. However, the mechanism causing the over expression is unknown.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4907,
        "geneSymbol": "NT5E",
        "terms": [
            "NT5E",
            "CALJA",
            "CD73",
            "E5NT",
            "eN",
            "eNT",
            "NT",
            "NT5",
            "NTE"
        ]
    },
    "variant": "over exp",
    "createDate": "08/01/2018",
    "updateDate": "08/01/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14956,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis, ERBB2 (HER2)-positive breast cancer patients with increased expression of NT5E (CD73) had no significant benefit to Herceptin (trastuzumab) (PMID: 28855210).",
            "molecularProfile": {
                "id": 30398,
                "profileName": "ERBB2 amp NT5E over exp"
            },
            "therapy": {
                "id": 947,
                "therapyName": "Trastuzumab",
                "synonyms": null
            },
            "indication": {
                "id": 60079,
                "name": "Her2-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 11853,
                    "pubMedId": 28855210,
                    "title": "CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28855210"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30397,
            "profileName": "NT5E over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30398,
            "profileName": "ERBB2 amp NT5E over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}